Abstract:Abstract Liver is the largest solid organ and performs hundreds of vital functions including drug metabolism. Liver diseases, including viral infections, cancer and metabolic disorders account for about 2 million deaths annually, worldwide (1). Current models for studying liver biology and drug metabolism include 2D cultured primary cells/cell lines, which do not represent the metabolic and structural complexity of human tissue. In vivo models for liver diseases are time consuming, cost prohibitive and often ineffective. Therefore, better tissue mimetic liver models are needed. Organoids are self-assembled 3D cultured cellular units that may mimic the corresponding human tissue structurally and functionally (2). Patient derived organoids (PDO) are developed from tissue of specific patients and may resemble the source tissue in molecular features, including recapitulation of patient specific responses to therapies. Here, we report development and characterization of novel liver PDO lines from vendor-sourced cryopreserved tissue. We have developed biobanks of undifferentiated as well as differentiated liver PDO models.Human cadaver-sourced liver tissue were obtained with explicit donor consent. Liver PDO were generated following modification of a previously established protocol (3). Briefly, samples were minced, digested to single cells, and filtered. Specific number of cells were mixed with diluted Matrigel (Corning) and added as small drops on cell culture plates and grown in liver PDO specific growth media. Whenever appropriate, PDO were differentiated by culturing in differentiation-specific media in multi-well plates. In all cases, PDO were monitored using brightfield microscopy (Olympus CK40) and live cell imaging (Muvicyte, Perkin Elmer); and passaged every 6-8 days. Undifferentiated PDO were cryopreserved/thawed following in-house SOP to confirm viability. Liver-specific biomarker expression in the PDO lines were confirmed by confocal microscopy (ImageExpress, Molecular Devices). PDO lines were also assayed for ALT activity, albumin production and urea. PDO were cleared for microbial/viral contamination and confirmed as unique lines using single tandem repeat analyses. Transcriptome profiles were analyzed using vendor services. So far, we have successfully generated 3 liver PDO lines, both undifferentiated as well as differentiated. Our liver PDO lines would be highly useful in understanding liver biology and disease models; and will have significant usage in drug testing, including DMPK and ADME/Tox studies. Future efforts would include scaling up, development of liver specific assays and developing PDO from specific liver diseases, including hepatocellular carcinoma, MASLD and NASH. References:1.Asrani, et al., 2019. J. Hepatol. 2.Zhao et al., 2022. STAR Protocols3.Broutier et al., 2016. Nature Protocols Citation Format: Rudra Bhowmick, Mahi Rahman, Sameena Wani, Sudarshan Malla, Anirban Chatterjee. Human liver patient derived organoids: Development and characterization of a new tissue mimetic model [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 2072.

Establishment and characterization of turtle liver organoids provides a potential model to decode their unique adaptations

RNA‐seq reveals a robust transcriptomic response during anoxia in the Western painted turtle

Development of the embryonic liver and pancreas of the Chinese softshell turtle Trionyx sinensis

Cell Isolation and Organoid Culture from Mouse Liver and Small Intestine

The Draft Genomes of Soft-Shell Turtle and Green Sea Turtle Yield Insights into the Development and Evolution of the Turtle-Specific Body Plan

Karyotypic Evolution of Sauropsid Vertebrates Illuminated by Optical and Physical Mapping of the Painted Turtle and Slider Turtle Genomes

Establishment and Cryopreservation of Liver, Heart and Muscle Cell Lines Derived from the Chinese Alligator (alligator Sinensis)

Shell biomechanics suggests an aquatic palaeoecology at the dawn of turtle evolution

Hypoxia exposure fine-tunes mitochondrial function in sea turtle cells

The shell bone histology of fossil and extant marine turtles revisited

Developmental programming of sarcoplasmic reticulum function improves cardiac anoxia tolerance in turtles

Delayed trait development and the convergent evolution of shell kinesis in turtles

Development of a High-Throughput Micropatterned Agarose Scaffold for Consistent and Reproducible Hpsc-Derived Liver Organoids.

Oxidative Damage? Not a Problem! The Characterization of Humanin-like Mitochondrial Peptide in Anoxia Tolerant Freshwater Turtles

Efficient Vascularization of Kidney Organoids through Intracelomic Transplantation in Chicken Embryos

Gene Regulatory Network Analysis and Engineering Directs Development and Vascularization of Multilineage Human Liver Organoids

Abstract 2072: Human liver patient derived organoids: Development and characterization of a new tissue mimetic model

Bioengineered Tubular Biliary Organoids

Modeling kidney development, disease, and plasticity with clonal expandable nephron progenitor cells and nephron organoids

Skull Development, Ossification Pattern, and Adult Shape in the Emerging Lizard Model Organism Pogona vitticeps: A Comparative Analysis With Other Squamates

Adult Animal Stem Cell-Derived Organoids in Biomedical Research and the One Health Paradigm